Repligen | RGEN - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Agilent USD 408M 44M 2026-03
Align Technology USD 148.69M 193K 2026-06
Bio Techne USD 106.09M 34.87M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Bruker USD 117M 95.1M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 137M 13M 2026-06
Illumina USD 260M 103M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pfizer USD -653M 5.84B 2026-06
Repligen USD 14.15M 12.38M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Standard Biotools USD -14.62M 7.42M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Waters USD 356M 444M 2026-06
West Pharmaceutical Services USD 180.1M 18.6M 2026-03